JYNT vs XPOF vs SKIN vs FXNC vs USPH

For growth investors, First National Corporation (FXNC) is the stronger pick with 27.

1% revenue growth year-over-year, versus -10. 0% for The Beauty Health Company (SKIN). First National Corporation (FXNC) offers the better valuation at 14. 3x trailing P/E (11. 7x forward), making it the more compelling value choice. Analysts rate The Joint Corp. (JYNT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, First National Corporation (FXNC) is the cheapest at 14.

3x versus The Joint Corp. at 45. 6x. On forward P/E, Xponential Fitness, Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, First National Corporation (FXNC) delivered a total return of +68.

7%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: FXNC returned +241. 1% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), First National Corporation (FXNC) is the lower-risk stock at 0.

70β versus The Beauty Health Company's 2. 00β — meaning SKIN is approximately 184% more volatile than FXNC relative to the S&P 500. On balance sheet safety, The Joint Corp. (JYNT) carries a lower debt/equity ratio of 13% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.

1% versus -10. 0% for The Beauty Health Company (SKIN). On earnings-per-share growth, the picture is similar: The Joint Corp. grew EPS 133. 9% year-over-year, compared to -22. 8% for U. S. Physical Therapy, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

First National Corporation (FXNC) is the more profitable company, earning 15.

8% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus -6. 9% for SKIN. At the gross margin level — before operating expenses — JYNT leads at 76. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Xponential Fitness, Inc.

(XPOF) trades at 10. 9x forward P/E versus 44. 9x for The Joint Corp. — 34. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JYNT: 130. 7% to $20. 00.

In this comparison, USPH (3.

1% yield), XPOF (2. 5% yield), FXNC (2. 2% yield) pay a dividend. JYNT, SKIN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, First National Corporation (FXNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

70), 2. 2% yield, +241. 1% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FXNC: +241. 1%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (JYNT (Healthcare) and XPOF (Consumer Cyclical) and SKIN (Consumer Defensive) and FXNC (Financial Services) and USPH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: JYNT is a small-cap quality compounder stock; XPOF is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; FXNC is a small-cap high-growth stock; USPH is a small-cap high-growth stock. XPOF, FXNC, USPH pay a dividend while JYNT, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.